Featuring an interview with Dr Jeffrey E Lancet about recent
data with induction and maintenance therapy for acute myeloid
leukemia, including the following topics:
Novel Induction and Maintenance Strategies in Acute Myeloid
Leukemia — Jeffrey E Lancet, MD (00:00)
Case: A man in his late 60s with secondary
AML, deletion 7q and mutations in RUNX1, TET2 and CUX1 receives
induction therapy with CPX-351 (29:55)
Case: A man in his mid-70s with a history of
myelodysplastic syndrome for 2 years develops secondary AML and
receives CPX-351 (33:35)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.